John D Abdulian, MD
Gastroenterology · Fresno
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Community Foundation Medical Group · 282 clinicians in this group
Hospitals listed: Clovis Community Medical Center · Community Regional Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Abdulian’s office at (559) 323-8200 to ask if they take your plan before you enroll.
State licence records
1 licence
- Texas M2891Physician License · since 2006 · expires 2015-11-30Canc Non-RenewalNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Clovis Community Medical CenterClovis, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Medical Centers, which runs 4 hospitalsPatients rate it 3 of 5 · 80% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.7 (12.1 to 17.7) · 421 cases, Jan 2024 – Dec 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.692, Oct 2024 – Sep 2025
- Community Regional Medical CenterFresno, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Medical Centers, which runs 4 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 1 of 5 starsWorse than the national rate — Death rate among surgical inpatients with serious treatable complications: 211.21 (174.88 to 247.54) · 239 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.705, Oct 2024 – Sep 2025
See every measure and the patient survey for Clovis Community Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 0 better, 6 the same, 1 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.7 (12.1 to 17.7) · 421 cases | Worse | Jan 2024 – Dec 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.692 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.97 (0.04 to 1.89) · 1,840 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.16 (0.86 to 1.45) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 217.06 (167.45 to 266.67) · 84 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 69 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.1 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.4 · 161 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 14 · 507 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.6 · 798 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 336 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 3,771 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.39) · 8,649 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.08 to 0.46) · 9,146 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.46 (1.47 to 5.45) · 1,654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.19 (0.61 to 3.78) · 387 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.18 (0.7 to 3.66) · 1,578 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.47 (7.08 to 19.87) · 374 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.99 (1.37 to 8.61) · 379 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.58 (0.13 to 3.04) · 405 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.8 (0.23 to 1.38) · 8,198 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 90 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.651 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.922 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.449 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.509 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.3 · 210 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 23 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -1.5 · 152 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 58.4 · 556 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18 · 769 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.8 · 802 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (4 to 7.4) · 421 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 91 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 93 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 200 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.8 to 15.6) · 2,398 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.1) · 720 cases | No different | Jan 2024 – Dec 2024 |
What patients said (441 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 80% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Community Regional Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 0 better, 7 the same, 0 worse of 7 measures. Readmissions: 0 better, 7 the same, 3 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 211.21 (174.88 to 247.54) · 239 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.705 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.13 (0.29 to 1.96) · 2,304 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.09 (0.87 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 116 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 187 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 445 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.2 · 399 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 582 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 3,744 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.5) · 11,052 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,566 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.33 (1.64 to 5.01) · 3,139 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.08 (0 to 2.3) · 1,423 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.7 (0.52 to 2.88) · 3,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.85 (8.11 to 15.6) · 1,481 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.4 (3.81 to 8.98) · 1,404 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.35 (0.95 to 3.76) · 760 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.64 (0.16 to 1.11) · 10,254 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.817 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.031 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.837 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.81 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 258 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 689 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 37.4 · 202 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 35.2 · 543 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.2 · 434 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.3 · 552 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.6 to 7.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.3 to 15.4) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 12.4 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.6 · 248 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.9 (9.5 to 14.9) · 2,590 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 310 cases | No different | Jan 2024 – Dec 2024 |
What patients said (421 patients answered, 26% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$138,759
Medicare paid this office $138,759 for 555 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 149 | $27,257 | $183 |
| Long return visit (40+ min) | 115 | $21,103 | $140 |
| Return visit (30+ min) | 159 | $15,931 | $87 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 149 | $11,762 | $77 |
| New patient visit (45+ min) | 71 | $8,662 | $122 |
See all 17 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 149 | $27,257 | $183 |
| Long return visit (40+ min) | 115 | $21,103 | $140 |
| Return visit (30+ min) | 159 | $15,931 | $87 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 149 | $11,762 | $77 |
| New patient visit (45+ min) | 71 | $8,662 | $122 |
| Biopsy of large bowel using a flexible endoscope | 117 | $7,007 | $60 |
| New patient visit (60+ min) | 39 | $6,904 | $177 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 22 | $3,698 | $168 |
| New patient visit (30+ min) | 56 | $3,506 | $63 |
| Destruction of polyp or growth of large bowel using a flexible endoscope | 17 | $3,404 | $200 |
| Diagnostic exam of large bowel using a flexible endoscope | 23 | $3,304 | $144 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 27 | $2,849 | $102 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 34 | $2,829 | $83 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 14 | $2,492 | $178 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $1,901 | $136 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 17 | $1,622 | $90 |
| Injection beneath lining of large bowel using a flexible endoscope | 13 | $307 | $24 |
Procedures Medicare counted
| Colonoscopy | 176 | More than 91% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 243 | More than 93% of doctors who do this |
Who their Medicare patients are
555 Original Medicare patients in 2024. Average age 74 · Under 65 6% · 85 and older 8% · Women 50% · Also on Medicaid 16% · Health risk score 1.20. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 75% · Coronary heart disease 40% · Diabetes 39% · Chronic kidney disease 34% · Heart failure 19% · Depression 19% · Cancer 17% · Atrial fibrillation 17% · COPD 13% · Stroke 6% · Dementia 5%.
The office billed $1,181,455, Medicare allowed $179,256 and paid $138,759; for 1,222 services of 52 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 555 | 1,222 | 74 | 1.20 | $1,181,455 | $138,759 |
| 2023 | 604 | 1,193 | 74 | 1.22 | $1,126,458 | $123,289 |
| 2022 | 706 | 1,397 | 74 | 1.24 | $1,299,390 | $140,287 |
| 2021 | 635 | 1,459 | 73 | 1.29 | $1,448,924 | $144,891 |
| 2020 | 574 | 1,316 | 73 | 1.37 | $1,032,194 | $118,965 |
| 2019 | 662 | 1,725 | 72 | 1.34 | $1,234,279 | $165,236 |
| 2018 | 689 | 1,831 | 73 | 1.38 | $1,254,395 | $173,968 |
| 2017 | 712 | 1,854 | 72 | 1.35 | $1,165,723 | $180,427 |
| 2016 | 704 | 1,631 | 72 | 1.38 | $1,052,869 | $179,908 |
| 2015 | 548 | 1,298 | 72 | 1.55 | $742,938 | $138,206 |
| 2014 | 528 | 1,410 | 71 | 1.59 | $744,414 | $145,092 |
| 2013 | 436 | 1,122 | 71 | 1.68 | $619,695 | $124,843 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 16 services
| Return visit (30+ min) | 219 | $27,377 | $95 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 115 | $19,702 | $171 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 160 | $13,023 | $78 |
| Biopsy of large bowel using a flexible endoscope | 129 | $10,503 | $81 |
| Long return visit (40+ min) | 47 | $7,564 | $145 |
| New patient visit (30+ min) | 94 | $7,465 | $79 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 28 | $5,185 | $185 |
| Destruction of polyp or growth of large bowel using a flexible endoscope | 19 | $4,056 | $213 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 41 | $3,552 | $87 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 17 | $3,152 | $185 |
| Diagnostic exam of large bowel using a flexible endoscope | 18 | $2,329 | $129 |
| New patient visit (15+ min) | 49 | $2,259 | $46 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $1,799 | $100 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 17 | $1,672 | $93 |
| New patient visit (45+ min) | 12 | $1,515 | $126 |
| Short return visit (20+ min) | 32 | $1,441 | $45 |
2022: 18 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 139 | $26,227 | $189 |
| Return visit (30+ min) | 197 | $24,541 | $100 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 203 | $16,186 | $79 |
| New patient visit (30+ min) | 149 | $12,637 | $85 |
| Biopsy of large bowel using a flexible endoscope | 155 | $11,896 | $77 |
| Short return visit (20+ min) | 111 | $6,960 | $58 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 31 | $5,682 | $183 |
| Long return visit (40+ min) | 28 | $4,160 | $134 |
| Diagnostic exam of large bowel using a flexible endoscope | 28 | $3,766 | $135 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 20 | $3,764 | $188 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 41 | $3,682 | $82 |
| New patient visit (15+ min) | 57 | $2,842 | $50 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,255 | $161 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 17 | $1,676 | $93 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,523 | $109 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $694 | $58 |
| Short return visit | 17 | $694 | $41 |
| Injection beneath lining of large bowel using a flexible endoscope | 13 | $171 | $13 |
2021: 20 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 127 | $21,922 | $173 |
| Return visit (30+ min) | 161 | $20,485 | $102 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 206 | $16,345 | $78 |
| Short return visit (20+ min) | 142 | $11,111 | $68 |
| Biopsy of large bowel using a flexible endoscope | 127 | $10,812 | $85 |
| New patient visit (30+ min) | 102 | $9,006 | $88 |
| Destruction of polyp or growth of large bowel using a flexible endoscope | 35 | $7,798 | $223 |
| Diagnostic exam of large bowel using a flexible endoscope | 40 | $6,024 | $151 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $4,284 | $165 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 41 | $3,971 | $92 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 19 | $3,649 | $192 |
| New patient visit (15+ min) | 63 | $3,307 | $52 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 18 | $3,261 | $181 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 31 | $2,602 | $59 |
| Telephone medical discussion with physician, 21-30 minutes | 33 | $2,055 | $60 |
| Long return visit (40+ min) | 12 | $1,728 | $144 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 13 | $1,593 | $114 |
| Telephone medical discussion with physician, 11-20 minutes | 21 | $901 | $41 |
| Injection beneath lining of large bowel using a flexible endoscope | 30 | $546 | $18 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 23 | $80 | $3 |
2020: 20 services
| Destruction of polyp or growth of large bowel using a flexible endoscope | 61 | $13,735 | $225 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 97 | $13,577 | $140 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 145 | $11,197 | $76 |
| Return visit (30+ min) | 110 | $9,708 | $77 |
| Biopsy of large bowel using a flexible endoscope | 91 | $9,024 | $98 |
| Telephone medical discussion with physician, 21-30 minutes | 72 | $7,071 | $92 |
| Short return visit (20+ min) | 83 | $5,509 | $60 |
| New patient visit (30+ min) | 66 | $5,060 | $77 |
| New patient visit (15+ min) | 76 | $4,234 | $56 |
| Telephone medical discussion with physician, 11-20 minutes | 63 | $4,234 | $61 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 42 | $3,748 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,372 | $169 |
| Long return visit (40+ min) | 30 | $3,227 | $98 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $3,205 | $60 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 16 | $2,819 | $176 |
| Diagnostic exam of large bowel using a flexible endoscope | 20 | $2,752 | $131 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 20 | $2,162 | $103 |
| Short return visit | 34 | $1,257 | $37 |
| Injection beneath lining of large bowel using a flexible endoscope | 22 | $450 | $20 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 45 | $165 | $4 |
2019: 20 services
| Return visit (30+ min) | 259 | $33,987 | $84 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 122 | $18,510 | $152 |
| New patient visit (30+ min) | 206 | $16,020 | $78 |
| Destruction of polyp or growth of large bowel using a flexible endoscope | 61 | $13,738 | $225 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 168 | $13,017 | $77 |
| Long return visit (40+ min) | 83 | $10,896 | $108 |
| Biopsy of large bowel using a flexible endoscope | 123 | $10,034 | $81 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $6,209 | $163 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 33 | $6,016 | $182 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 44 | $3,602 | $80 |
| New patient visit (45+ min) | 30 | $3,417 | $114 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 17 | $3,269 | $192 |
| Short return visit (20+ min) | 42 | $2,575 | $57 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 20 | $2,324 | $93 |
| Insertion of guide wire with dilation of esophagus using a flexible endoscope | 16 | $2,222 | $131 |
| Diagnostic exam of large bowel using a flexible endoscope | 15 | $2,079 | $139 |
| New patient visit (15+ min) | 29 | $1,582 | $55 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,480 | $59 |
| Injection beneath lining of large bowel using a flexible endoscope | 26 | $504 | $19 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 86 | $365 | $4 |
2018: 20 services
| Return visit (30+ min) | 234 | $28,349 | $81 |
| Long return visit (40+ min) | 124 | $18,678 | $111 |
| New patient visit (30+ min) | 204 | $16,625 | $81 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 199 | $15,701 | $76 |
| Biopsy of large bowel using a flexible endoscope | 140 | $14,392 | $101 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 85 | $11,957 | $141 |
| New patient visit (45+ min) | 86 | $9,875 | $115 |
| Destruction of polyp or growth of large bowel using a flexible endoscope | 44 | $9,735 | $221 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 45 | $7,300 | $155 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 29 | $5,216 | $180 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 51 | $4,429 | $87 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 16 | $2,964 | $185 |
| Diagnostic exam of large bowel using a flexible endoscope | 18 | $2,565 | $142 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 21 | $2,507 | $104 |
| Insertion of guide wire with dilation of esophagus using a flexible endoscope | 18 | $2,487 | $131 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $2,179 | $59 |
| Short return visit (20+ min) | 39 | $2,173 | $56 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,350 | $84 |
| Injection beneath lining of large bowel using a flexible endoscope | 32 | $743 | $23 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 109 | $463 | $4 |
2017: 22 services
| Return visit (30+ min) | 246 | $27,784 | $78 |
| New patient visit (45+ min) | 195 | $22,540 | $116 |
| Long return visit (40+ min) | 152 | $21,117 | $111 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 199 | $15,980 | $78 |
| Biopsy of large bowel using a flexible endoscope | 136 | $15,820 | $116 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 83 | $15,685 | $189 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 39 | $7,551 | $189 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 36 | $6,402 | $164 |
| New patient visit (30+ min) | 75 | $5,107 | $68 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 58 | $4,939 | $84 |
| Insertion of guide wire with dilation of esophagus using a flexible endoscope | 28 | $3,740 | $125 |
| Diagnostic exam of large bowel using a flexible endoscope | 26 | $3,414 | $131 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 11 | $3,142 | $196 |
| New patient visit (60+ min) | 16 | $2,346 | $147 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 20 | $2,310 | $116 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 12 | $2,256 | $174 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $1,816 | $59 |
| Short return visit (20+ min) | 21 | $1,202 | $57 |
| Injection beneath lining of large bowel using a flexible endoscope | 37 | $821 | $22 |
| Review by radiologist of image from tube placement into bile duct using an endoscope | 17 | $646 | $29 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 123 | $546 | $4 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $444 | $32 |
2016: 18 services
| New patient visit (45+ min) | 210 | $25,840 | $123 |
| Return visit (30+ min) | 178 | $21,059 | $85 |
| Long return visit (40+ min) | 152 | $20,396 | $110 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 87 | $16,866 | $192 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 187 | $14,471 | $76 |
| Biopsy of large bowel using a flexible endoscope | 145 | $14,439 | $99 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 49 | $8,081 | $158 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 39 | $7,783 | $195 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 31 | $6,140 | $198 |
| New patient visit (30+ min) | 73 | $5,732 | $79 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 44 | $4,852 | $58 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 48 | $4,482 | $90 |
| New patient visit (60+ min) | 19 | $3,174 | $167 |
| Diagnostic exam of large bowel using a flexible endoscope | 21 | $3,115 | $148 |
| Insertion of guide wire with dilation of esophagus using a flexible endoscope | 21 | $2,713 | $123 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $2,444 | $84 |
| Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | 13 | $1,512 | $101 |
| Injection beneath lining of large bowel using a flexible endoscope | 20 | $680 | $32 |
2015: 19 services
| New patient visit (45+ min) | 202 | $24,841 | $123 |
| Return visit (30+ min) | 177 | $19,628 | $74 |
| Biopsy of large bowel using a flexible endoscope | 116 | $18,001 | $154 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 144 | $13,119 | $89 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 49 | $11,400 | $233 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 48 | $5,033 | $103 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 46 | $4,558 | $54 |
| Long return visit (40+ min) | 40 | $4,517 | $108 |
| New patient visit (30+ min) | 44 | $3,602 | $82 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 17 | $3,492 | $205 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 32 | $3,482 | $97 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $3,474 | $145 |
| Diagnostic exam of large bowel using a flexible endoscope | 20 | $3,313 | $166 |
| New patient visit (60+ min) | 16 | $2,505 | $157 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 11 | $2,009 | $183 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 17 | $1,873 | $78 |
| Short return visit (20+ min) | 31 | $1,657 | $52 |
| Injection beneath lining of large bowel using a flexible endoscope | 28 | $622 | $21 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 13 | $396 | $26 |
2014: 19 services
| Return visit (30+ min) | 204 | $25,190 | $77 |
| New patient visit (45+ min) | 159 | $17,789 | $112 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 154 | $15,323 | $96 |
| Biopsy of large bowel using a flexible endoscope | 91 | $13,613 | $148 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 73 | $11,641 | $155 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 48 | $10,212 | $213 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 72 | $7,226 | $56 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 26 | $5,395 | $208 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 41 | $3,748 | $91 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 31 | $3,319 | $107 |
| Diagnostic exam of large bowel using a flexible endoscope | 20 | $3,302 | $165 |
| New patient visit (30+ min) | 42 | $3,227 | $77 |
| Long return visit (40+ min) | 29 | $3,093 | $103 |
| Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $2,619 | $164 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 22 | $2,263 | $78 |
| Short return visit (20+ min) | 39 | $2,129 | $51 |
| New patient visit (60+ min) | 14 | $1,886 | $135 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 22 | $733 | $31 |
| New patient visit (15+ min) | 12 | $666 | $56 |
2013: 13 services
| Return visit (30+ min) | 200 | $22,500 | $75 |
| New patient visit (45+ min) | 153 | $17,618 | $115 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 140 | $16,322 | $117 |
| Biopsy of large bowel using a flexible endoscope | 94 | $15,260 | $161 |
| Long return visit (40+ min) | 74 | $9,595 | $102 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 29 | $6,679 | $230 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 41 | $6,533 | $148 |
| New patient visit (60+ min) | 42 | $6,137 | $146 |
| Diagnostic exam of large bowel using a flexible endoscope | 25 | $4,135 | $165 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 22 | $2,717 | $104 |
| Insertion of guide wire with dilation of esophagus using a flexible endoscope | 13 | $2,007 | $143 |
| New patient visit (30+ min) | 19 | $1,452 | $76 |
| Short return visit (20+ min) | 29 | $1,401 | $48 |
Drugs they prescribed that Part D paid
$483,665
Pharmacies billed $483,665 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,697) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
1,569 generic and 128 brand-name prescriptions · $483,665 in drug cost · 50 antibiotic prescriptions to 20 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Humira | 13 | $101,846 | $7,834 |
| Linzess | 24 | $29,794 | $1,241 |
| Voquezna | 13 | $17,709 | $1,362 |
| Mesalamine | 18 | $10,509 | $584 |
| Pantoprazole | 611 | $8,568 | $14 |
See all 23 drugs
| Humira | 13 | $101,846 | $7,834 |
| Linzess | 24 | $29,794 | $1,241 |
| Voquezna | 13 | $17,709 | $1,362 |
| Mesalamine | 18 | $10,509 | $584 |
| Pantoprazole | 611 | $8,568 | $14 |
| Famotidine | 230 | $5,099 | $22 |
| Ursodiol | 20 | $4,667 | $233 |
| Omeprazole | 158 | $2,355 | $15 |
| Baclofen | 111 | $1,946 | $18 |
| Azathioprine | 23 | $1,582 | $69 |
| Dicyclomine | 47 | $809 | $17 |
| Ondansetron | 25 | $657 | $26 |
| Duloxetine | 25 | $649 | $26 |
| Esomeprazole Magnesium | 13 | $563 | $43 |
| Amitriptyline | 37 | $527 | $14 |
| Lansoprazole | 13 | $366 | $28 |
| Spironolactone | 12 | $268 | $22 |
| Pioglitazone | 18 | $219 | $12 |
| Metoclopramide | 20 | $170 | $9 |
| Metronidazole | 14 | $98 | $7 |
| Furosemide | 15 | $86 | $6 |
| Prednisone | 13 | $82 | $6 |
| Amoxicillin | 14 | $80 | $6 |
Year by year
| 2024 | 1,697 | 474 | 0% (0) | 8% | $483,665 |
| 2023 | 1,722 | 456 | 0% (0) | 9% | $638,532 |
| 2022 | 1,719 | 450 | 0% (0) | None | $377,339 |
| 2021 | 1,556 | 422 | 0% (0) | 8% | $564,863 |
| 2020 | 1,754 | 526 | None | 13% | $560,983 |
| 2019 | 1,814 | 603 | 0% (0) | None | $924,743 |
| 2018 | 1,689 | 504 | 0% (0) | None | $1,094,220 |
| 2017 | 1,285 | 355 | None | None | $553,302 |
| 2016 | 1,176 | 374 | None | 20% | $565,907 |
| 2015 | 1,350 | 421 | None | 32% | $171,164 |
| 2014 | 1,521 | 418 | 0% (0) | 30% | $169,171 |
| 2013 | 1,162 | 334 | None | 34% | $133,867 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 24 drugs
| Humira | 21 | $154,551 | $7,360 |
| Creon | 14 | $46,365 | $3,312 |
| Mesalamine | 28 | $30,461 | $1,088 |
| Linzess | 23 | $17,904 | $778 |
| Pantoprazole | 583 | $11,748 | $20 |
| Ursodiol | 18 | $8,025 | $446 |
| Famotidine | 229 | $6,537 | $29 |
| Azathioprine | 39 | $6,090 | $156 |
| Budesonide Ec | 24 | $5,082 | $212 |
| Sutab | 23 | $3,834 | $167 |
| Omeprazole | 131 | $2,678 | $20 |
| Baclofen | 96 | $2,530 | $26 |
| Misoprostol | 18 | $2,360 | $131 |
| Dicyclomine | 77 | $1,925 | $25 |
| Sucralfate | 16 | $1,329 | $83 |
| Amitriptyline | 43 | $753 | $18 |
| Duloxetine | 15 | $698 | $47 |
| Doxycycline Monohydrate | 18 | $418 | $23 |
| Ondansetron | 31 | $341 | $11 |
| Metronidazole | 30 | $315 | $10 |
| Metoclopramide | 17 | $237 | $14 |
| Furosemide | 15 | $198 | $13 |
| Prednisone | 11 | $158 | $14 |
| Allopurinol | 14 | $111 | $8 |
2022: 26 drugs
| Humira | 13 | $89,517 | $6,886 |
| Linzess | 21 | $16,760 | $798 |
| Mesalamine | 20 | $12,746 | $637 |
| Pantoprazole | 578 | $10,380 | $18 |
| Ursodiol | 23 | $9,926 | $432 |
| Budesonide Ec | 13 | $7,533 | $579 |
| Azathioprine | 42 | $5,037 | $120 |
| Esomeprazole Magnesium | 11 | $4,819 | $438 |
| Famotidine | 206 | $4,670 | $23 |
| Misoprostol | 27 | $3,546 | $131 |
| Sutab | 21 | $3,344 | $159 |
| Baclofen | 87 | $2,630 | $30 |
| Lactulose | 20 | $2,380 | $119 |
| Omeprazole | 129 | $1,872 | $15 |
| Dicyclomine | 68 | $1,597 | $23 |
| Duloxetine | 33 | $1,480 | $45 |
| Sucralfate | 38 | $1,337 | $35 |
| Amitriptyline | 44 | $699 | $16 |
| Ondansetron | 46 | $660 | $14 |
| Doxycycline Monohydrate | 14 | $376 | $27 |
| Spironolactone | 17 | $344 | $20 |
| Metronidazole | 23 | $223 | $10 |
| Metoclopramide | 16 | $217 | $14 |
| Prednisone | 12 | $156 | $13 |
| Furosemide | 21 | $115 | $5 |
| Allopurinol | 12 | $75 | $6 |
2021: 25 drugs
| Humira | 12 | $75,199 | $6,267 |
| Xifaxan | 15 | $49,570 | $3,305 |
| Linzess | 26 | $24,472 | $941 |
| Mesalamine | 17 | $14,930 | $878 |
| Ursodiol | 39 | $10,365 | $266 |
| Pantoprazole | 476 | $9,050 | $19 |
| Famotidine | 183 | $5,462 | $30 |
| Budesonide Ec | 11 | $5,105 | $464 |
| Azathioprine | 34 | $3,386 | $100 |
| Omeprazole | 159 | $2,793 | $18 |
| Baclofen | 81 | $2,086 | $26 |
| Ondansetron | 53 | $1,798 | $34 |
| Lactulose | 11 | $1,725 | $157 |
| Misoprostol | 11 | $1,319 | $120 |
| Sucralfate | 16 | $924 | $58 |
| Duloxetine | 25 | $921 | $37 |
| Doxycycline Monohydrate | 21 | $831 | $40 |
| Dicyclomine | 38 | $826 | $22 |
| Amitriptyline | 29 | $456 | $16 |
| Gabapentin | 14 | $451 | $32 |
| Metronidazole | 23 | $315 | $14 |
| Prednisone | 22 | $300 | $14 |
| Spironolactone | 13 | $296 | $23 |
| Propranolol | 11 | $241 | $22 |
| Metoclopramide | 19 | $239 | $13 |
2020: 28 drugs
| Humira | 15 | $99,326 | $6,622 |
| Xifaxan | 17 | $65,374 | $3,846 |
| Mesalamine | 18 | $23,248 | $1,292 |
| Ursodiol | 44 | $21,232 | $483 |
| Linzess | 19 | $14,036 | $739 |
| Budesonide Ec | 13 | $11,643 | $896 |
| Amitiza | 16 | $9,277 | $580 |
| Pantoprazole | 435 | $8,442 | $19 |
| Famotidine | 140 | $5,448 | $39 |
| Baclofen | 104 | $3,360 | $32 |
| Omeprazole | 173 | $2,932 | $17 |
| Gavilyte-G | 134 | $1,732 | $13 |
| Azathioprine | 25 | $1,594 | $64 |
| Misoprostol | 17 | $1,427 | $84 |
| Dicyclomine | 63 | $1,342 | $21 |
| Sucralfate | 23 | $1,314 | $57 |
| Ondansetron | 46 | $1,192 | $26 |
| Diphenoxylate-Atropine | 19 | $1,159 | $61 |
| Sulfasalazine | 15 | $606 | $40 |
| Peg-3350 and Electrolytes | 47 | $558 | $12 |
| Duloxetine | 12 | $478 | $40 |
| Metoclopramide | 36 | $458 | $13 |
| Amitriptyline | 26 | $425 | $16 |
| Doxycycline Monohydrate | 13 | $368 | $28 |
| Metronidazole | 23 | $367 | $16 |
| Spironolactone | 11 | $307 | $28 |
| Gabapentin | 14 | $244 | $17 |
| Prednisone | 24 | $210 | $9 |
2019: 36 drugs
| Stelara | 13 | $287,606 | $22,124 |
| Humira | 13 | $127,932 | $9,841 |
| Xifaxan | 17 | $71,011 | $4,177 |
| Humira | 13 | $70,626 | $5,433 |
| Apriso | 19 | $21,429 | $1,128 |
| Linzess | 31 | $19,442 | $627 |
| Ursodiol | 47 | $19,366 | $412 |
| Budesonide Ec | 26 | $14,152 | $544 |
| Movantik | 15 | $9,786 | $652 |
| Dexilant | 16 | $9,132 | $571 |
| Suprep | 87 | $8,500 | $98 |
| Amitiza | 12 | $7,008 | $584 |
| Pantoprazole | 364 | $6,387 | $18 |
| Omeprazole | 194 | $3,667 | $19 |
| Trexall | 12 | $2,182 | $182 |
| Gavilyte-G | 156 | $2,118 | $14 |
| Baclofen | 96 | $2,065 | $22 |
| Diphenoxylate-Atropine | 28 | $1,897 | $68 |
| Famotidine | 85 | $1,533 | $18 |
| Ondansetron Odt | 13 | $1,499 | $115 |
| Ranitidine | 55 | $1,466 | $27 |
| Azathioprine | 18 | $1,153 | $64 |
| Ondansetron | 40 | $1,075 | $27 |
| Misoprostol | 12 | $1,012 | $84 |
| Sucralfate | 19 | $936 | $49 |
| Sulfasalazine | 21 | $764 | $36 |
| Amitriptyline | 39 | $489 | $13 |
| Metoclopramide | 35 | $438 | $13 |
| Spironolactone | 16 | $363 | $23 |
| Dicyclomine | 24 | $361 | $15 |
| Doxycycline Monohydrate | 13 | $262 | $20 |
| Peg-3350 and Electrolytes | 21 | $258 | $12 |
| Metronidazole | 13 | $190 | $15 |
| Gabapentin | 15 | $181 | $12 |
| Imipramine | 13 | $92 | $7 |
| Clonidine | 15 | $65 | $4 |
2018: 33 drugs
| Humira | 13 | $120,338 | $9,257 |
| Humira | 13 | $66,351 | $5,104 |
| Xifaxan | 13 | $49,376 | $3,798 |
| Budesonide Ec | 26 | $24,160 | $929 |
| Ursodiol | 45 | $20,203 | $449 |
| Apriso | 16 | $19,091 | $1,193 |
| Suprep | 161 | $14,934 | $93 |
| Linzess | 16 | $9,549 | $597 |
| Movantik | 24 | $9,032 | $376 |
| Carafate | 13 | $6,345 | $488 |
| Esomeprazole Magnesium | 20 | $4,552 | $228 |
| Omeprazole | 247 | $4,512 | $18 |
| Mercaptopurine | 13 | $4,104 | $316 |
| Pantoprazole | 248 | $3,779 | $15 |
| Diphenoxylate-Atropine | 55 | $1,743 | $32 |
| Ranitidine | 68 | $1,564 | $23 |
| Misoprostol | 14 | $1,457 | $104 |
| Sucralfate | 33 | $1,246 | $38 |
| Baclofen | 54 | $1,016 | $19 |
| Ondansetron | 23 | $854 | $37 |
| Famotidine | 65 | $785 | $12 |
| Metronidazole | 29 | $712 | $25 |
| Metoclopramide | 37 | $690 | $19 |
| Azathioprine | 15 | $620 | $41 |
| Sulfasalazine | 18 | $618 | $34 |
| Polyethylene Glycol 3350 | 25 | $616 | $25 |
| Amitriptyline | 32 | $412 | $13 |
| Doxycycline Monohydrate | 19 | $397 | $21 |
| Promethazine | 19 | $375 | $20 |
| Dicyclomine | 24 | $332 | $14 |
| Gabapentin | 24 | $238 | $10 |
| Clonidine | 28 | $134 | $5 |
| Imipramine | 12 | $61 | $5 |
2017: 27 drugs
| Humira | 11 | $47,510 | $4,319 |
| Xifaxan | 12 | $33,416 | $2,785 |
| Lialda | 14 | $26,302 | $1,879 |
| Ursodiol | 32 | $14,020 | $438 |
| Amitiza | 12 | $5,627 | $469 |
| Omeprazole | 291 | $5,265 | $18 |
| Linzess | 11 | $3,920 | $356 |
| Esomeprazole Magnesium | 23 | $3,916 | $170 |
| Pantoprazole | 192 | $3,331 | $17 |
| Misoprostol | 24 | $2,644 | $110 |
| Polyethylene Glycol 3350 | 35 | $917 | $26 |
| Diphenoxylate-Atropine | 23 | $858 | $37 |
| Ranitidine | 47 | $852 | $18 |
| Sucralfate | 24 | $755 | $31 |
| Baclofen | 43 | $743 | $17 |
| Famotidine | 55 | $618 | $11 |
| Sulfasalazine | 11 | $399 | $36 |
| Spironolactone | 13 | $348 | $27 |
| Metoclopramide | 25 | $338 | $14 |
| Metronidazole | 19 | $278 | $15 |
| Gabapentin | 31 | $276 | $9 |
| Dicyclomine | 38 | $253 | $7 |
| Prednisone | 12 | $241 | $20 |
| Amitriptyline | 14 | $154 | $11 |
| Gavilyte-G | 12 | $140 | $12 |
| Clonidine | 18 | $123 | $7 |
| Imipramine | 14 | $62 | $4 |
2016: 22 drugs
| Ursodiol | 32 | $21,364 | $668 |
| Lialda | 13 | $15,855 | $1,220 |
| Dexilant | 29 | $8,911 | $307 |
| Nexium | 14 | $7,098 | $507 |
| Linzess | 15 | $4,862 | $324 |
| Esomeprazole Magnesium | 14 | $3,147 | $225 |
| Omeprazole | 214 | $3,091 | $14 |
| Pantoprazole | 174 | $1,907 | $11 |
| Carafate | 12 | $1,748 | $146 |
| Polyethylene Glycol 3350 | 35 | $1,021 | $29 |
| Gavilyte-G | 74 | $982 | $13 |
| Baclofen | 65 | $888 | $14 |
| Ranitidine | 27 | $698 | $26 |
| Peg-3350 and Electrolytes | 54 | $672 | $12 |
| Famotidine | 51 | $637 | $12 |
| Sucralfate | 25 | $497 | $20 |
| Gabapentin | 34 | $238 | $7 |
| Dicyclomine | 33 | $202 | $6 |
| Metronidazole | 13 | $202 | $16 |
| Metoclopramide | 17 | $117 | $7 |
| Clonidine | 15 | $64 | $4 |
| Amlodipine Besylate | 11 | $42 | $4 |
2015: 22 drugs
| Nexium | 72 | $27,484 | $382 |
| Lialda | 12 | $13,354 | $1,113 |
| Suprep | 130 | $10,526 | $81 |
| Dexilant | 33 | $9,005 | $273 |
| Amitiza | 15 | $4,954 | $330 |
| Linzess | 19 | $4,546 | $239 |
| Pantoprazole | 245 | $2,680 | $11 |
| Baclofen | 177 | $2,310 | $13 |
| Omeprazole | 180 | $1,562 | $9 |
| Misoprostol | 13 | $939 | $72 |
| Gavilyte-G | 27 | $379 | $14 |
| Diphenoxylate-Atropine | 12 | $333 | $28 |
| Gabapentin | 27 | $263 | $10 |
| Peg-3350 and Electrolytes | 19 | $261 | $14 |
| Amitriptyline | 30 | $241 | $8 |
| Famotidine | 18 | $229 | $13 |
| Metronidazole | 13 | $228 | $18 |
| Promethazine | 11 | $202 | $18 |
| Metoclopramide | 20 | $119 | $6 |
| Methotrexate | 12 | $93 | $8 |
| Dicyclomine | 17 | $90 | $5 |
| Clonidine | 17 | $35 | $2 |
2014: 25 drugs
| Nexium | 61 | $21,807 | $357 |
| Suprep | 120 | $9,409 | $78 |
| Dexilant | 30 | $8,933 | $298 |
| Apriso | 22 | $8,548 | $389 |
| Pentasa | 11 | $8,124 | $739 |
| Amitiza | 21 | $5,413 | $258 |
| Linzess | 19 | $4,686 | $247 |
| Omeprazole-Sodium Bicarbonate | 13 | $3,982 | $306 |
| Pantoprazole | 276 | $3,249 | $12 |
| Omeprazole | 219 | $2,409 | $11 |
| Baclofen | 199 | $1,996 | $10 |
| Megestrol Acetate | 15 | $1,510 | $101 |
| Sulfasalazine | 21 | $764 | $36 |
| Promethazine | 18 | $480 | $27 |
| Gabapentin | 50 | $437 | $9 |
| Ranitidine | 13 | $372 | $29 |
| Gavilyte-N | 26 | $345 | $13 |
| Dicyclomine | 25 | $336 | $13 |
| Peg-3350 | 18 | $256 | $14 |
| Ciprofloxacin | 29 | $241 | $8 |
| Prednisone | 20 | $190 | $10 |
| Famotidine | 17 | $182 | $11 |
| Clonidine | 39 | $168 | $4 |
| Amitriptyline | 43 | $168 | $4 |
| Imipramine | 13 | $70 | $5 |
2013: 21 drugs
| Budesonide Ec | 29 | $30,483 | $1,051 |
| Pentasa | 18 | $14,304 | $795 |
| Dexilant | 55 | $10,870 | $198 |
| Nexium | 34 | $9,973 | $293 |
| Suprep | 78 | $5,648 | $72 |
| Amitiza | 14 | $3,490 | $249 |
| Moviprep | 49 | $3,461 | $71 |
| Omeprazole-Sodium Bicarbonate | 12 | $3,402 | $283 |
| Omeprazole | 208 | $2,801 | $13 |
| Linzess | 11 | $2,457 | $223 |
| Pantoprazole | 126 | $2,214 | $18 |
| Sulfazine | 14 | $1,067 | $76 |
| Baclofen | 126 | $809 | $6 |
| Ciprofloxacin | 44 | $351 | $8 |
| Famotidine | 34 | $346 | $10 |
| Sulfasalazine | 12 | $309 | $26 |
| Metronidazole | 14 | $282 | $20 |
| Gabapentin | 19 | $265 | $14 |
| Dicyclomine | 32 | $204 | $6 |
| Gavilyte-N | 11 | $171 | $16 |
| Amitriptyline | 25 | $82 | $3 |
Money from drug and device companies
$2,632 in 2025
| 2025 | 18 | 129 | None | $2,632 |
| 2024 | 19 | 150 | None | $3,057 |
| 2023 | 15 | 111 | None | $1,683 |
| 2022 | 16 | 140 | None | $2,129 |
| 2021 | 10 | 55 | None | $816 |
| 2020 | 5 | 6 | None | $102 |
| 2019 | 12 | 33 | None | $687 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Rinvoq | $802 | 47 payments
|
| Boston Scientific | Axios | $437 | 7 payments
|
| Janssen Biotech | Tremfya | $325 | 15 payments
|
| Aimmune Therapeutics | Vowst | $224 | 29 payments
|
| Madrigal Pharmaceuticals | Rezdiffra | $202 | 5 payments
|
| Phathom Pharmaceuticals | Voquezna | $138 | 6 payments
|
See all 129 published payments
| Abbvie | Meals · 2025-12-18 | Rinvoq | $21 |
| Abbvie | Meals · 2025-12-16 | Rinvoq | $17 |
| Pfizer | Meals · 2025-12-15 | Velsipity | $17 |
| Janssen Biotech | Meals · 2025-12-10 | Tremfya | $21 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-12-09 | Xifaxan | $17 |
| Aimmune Therapeutics | Meals · 2025-12-09 | Vowst | $8 |
| Abbvie | Meals · 2025-12-04 | Creon | $26 |
| Aimmune Therapeutics | Meals · 2025-12-02 | Vowst | $12 |
| Phathom Pharmaceuticals | Meals · 2025-12-01 | Voquezna | $18 |
| Janssen Biotech | Meals · 2025-11-21 | Tremfya | $18 |
| Aimmune Therapeutics | Meals · 2025-11-18 | Vowst | $12 |
| Abbvie | Meals · 2025-11-17 | Linzess | $2 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-11-17 | Xifaxan | $25 |
| Phathom Pharmaceuticals | Meals · 2025-11-15 | Voquezna | $20 |
| Janssen Biotech | Meals · 2025-11-14 | Tremfya | $26 |
| Janssen Biotech | Meals · 2025-11-08 | Tremfya | $22 |
| Phathom Pharmaceuticals | Meals · 2025-11-05 | Voquezna | $14 |
| Abbvie | Meals · 2025-11-04 | Linzess | $22 |
| Aimmune Therapeutics | Meals · 2025-11-04 | Vowst | $11 |
| Abbvie | Meals · 2025-10-31 | Skyrizi | $17 |
| Aimmune Therapeutics | Meals · 2025-10-30 | Vowst | $6 |
| Abbvie | Meals · 2025-10-23 | Rinvoq | $10 |
| Aimmune Therapeutics | Meals · 2025-10-23 | Vowst | $5 |
| Abbvie | Meals · 2025-10-14 | Rinvoq | $22 |
| Phathom Pharmaceuticals | Meals · 2025-10-14 | Voquezna | $5 |
| Aimmune Therapeutics | Meals · 2025-10-14 | Vowst | $7 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-10-13 | Xifaxan | $24 |
| Abbvie | Meals · 2025-10-09 | Rinvoq | $9 |
| Regeneron Healthcare Solutions | Meals · 2025-10-09 | Dupixent | $24 |
| Abbvie | Meals · 2025-10-07 | Rinvoq | $19 |
| Abbvie | Meals · 2025-10-06 | Linzess | $7 |
| Gilead Sciences | Meals · 2025-09-30 | None | $22 |
| Aimmune Therapeutics | Meals · 2025-09-25 | Vowst | $6 |
| Abbvie | Meals · 2025-09-24 | Linzess | $26 |
| Orphalan | Meals · 2025-09-23 | Cuvrior | $30 |
| Aimmune Therapeutics | Meals · 2025-09-23 | Vowst | $9 |
| Abbvie | Meals · 2025-09-17 | Linzess | $22 |
| Cook Medical | Meals · 2025-09-16 | Echotip Insight | $97 |
| Aimmune Therapeutics | Meals · 2025-09-16 | Vowst | $11 |
| Abbvie | Meals · 2025-09-04 | Rinvoq | $10 |
| Aimmune Therapeutics | Meals · 2025-09-04 | Vowst | $10 |
| Abbvie | Meals · 2025-08-29 | Linzess | $22 |
| Janssen Biotech | Meals · 2025-08-26 | Tremfya | $19 |
| Janssen Biotech | Meals · 2025-08-21 | Tremfya | $23 |
| Lilly USA | Meals · 2025-08-21 | Omvoh | $22 |
| Aimmune Therapeutics | Meals · 2025-08-21 | Vowst | $4 |
| Micro-tech Endoscopy USA | Meals · 2025-08-20 | Riteclip | $14 |
| Abbvie | Meals · 2025-08-14 | Rinvoq | $21 |
| Abbvie | Meals · 2025-08-13 | Rinvoq | $21 |
| Aimmune Therapeutics | Meals · 2025-08-12 | Vowst | $10 |
| Abbvie | Meals · 2025-07-31 | Rinvoq | $22 |
| Abbvie | Meals · 2025-07-29 | Rinvoq | $21 |
| Abbvie | Meals · 2025-07-28 | Linzess | $28 |
| Janssen Biotech | Meals · 2025-07-25 | Tremfya | $26 |
| Abbvie | Meals · 2025-07-22 | Creon | $15 |
| Abbvie | Meals · 2025-07-16 | Rinvoq | $25 |
| Aimmune Therapeutics | Meals · 2025-07-15 | Vowst | $7 |
| Abbvie | Meals · 2025-07-11 | Linzess | $35 |
| Gilead Sciences | Meals · 2025-07-11 | None | $25 |
| Abbvie | Meals · 2025-07-10 | Rinvoq | $21 |
| Abbvie | Meals · 2025-06-26 | Creon | $4 |
| Abbvie | Meals · 2025-06-26 | Linzess | $15 |
| Aimmune Therapeutics | Meals · 2025-06-19 | Vowst | $10 |
| Abbvie | Meals · 2025-06-17 | Rinvoq | $14 |
| Pfizer | Meals · 2025-06-16 | Xeljanz | $21 |
| Boston Scientific | Meals · 2025-06-12 | Axios | $181 |
| Abbvie | Meals · 2025-06-10 | Rinvoq | $22 |
| Aimmune Therapeutics | Meals · 2025-06-05 | Vowst | $9 |
| Aimmune Therapeutics | Meals · 2025-06-04 | Vowst | $8 |
| Abbvie | Meals · 2025-05-30 | Linzess | $21 |
| Janssen Biotech | Meals · 2025-05-27 | Tremfya | $30 |
| Aimmune Therapeutics | Meals · 2025-05-22 | Vowst | $6 |
| Abbvie | Meals · 2025-05-20 | Skyrizi | $13 |
| Pfizer | Meals · 2025-05-20 | Xeljanz | $19 |
| Abbvie | Meals · 2025-05-15 | Rinvoq | $22 |
| Phathom Pharmaceuticals | Meals · 2025-05-13 | Voquezna | $73 |
| Madrigal Pharmaceuticals | Meals · 2025-05-09 | Rezdiffra | $25 |
| Abbvie | Meals · 2025-05-08 | Rinvoq | $18 |
| Aimmune Therapeutics | Meals · 2025-05-07 | Vowst | $7 |
| Abbvie | Meals · 2025-05-06 | Creon | $25 |
| Janssen Biotech | Meals · 2025-05-01 | Tremfya | $24 |
| Abbvie | Meals · 2025-04-29 | Rinvoq | $5 |
| Abbvie | Meals · 2025-04-29 | Linzess | $24 |
| Janssen Biotech | Meals · 2025-04-25 | Tremfya | $24 |
| Aimmune Therapeutics | Meals · 2025-04-25 | Vowst | $4 |
| Abbvie | Meals · 2025-04-22 | Rinvoq | $14 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-04-22 | Xifaxan | $23 |
| Boston Scientific | Meals · 2025-04-18 | General - Hemostasis | $51 |
| Abbvie | Meals · 2025-04-18 | Skyrizi | $18 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-04-15 | Entyvio | $27 |
| Ardelyx | Meals · 2025-04-11 | Ibsrela | $20 |
| Janssen Biotech | Meals · 2025-04-10 | Tremfya | $21 |
| Boston Scientific | Meals · 2025-04-09 | General - Hemostasis | $34 |
| Lilly USA | Meals · 2025-04-08 | Omvoh | $29 |
| Janssen Biotech | Meals · 2025-04-03 | Tremfya | $1 |
| Abbvie | Meals · 2025-04-03 | Rinvoq | $3 |
| Janssen Biotech | Meals · 2025-03-29 | Tremfya | $24 |
| Aimmune Therapeutics | Meals · 2025-03-25 | Vowst | $5 |
| Boston Scientific | Meals · 2025-03-20 | General - Metal Stents - G.I. | $39 |
| Boston Scientific | Meals · 2025-03-18 | X-Tack Endoscopic Helix Tacking System | $52 |
| Aimmune Therapeutics | Meals · 2025-03-18 | Vowst | $10 |
| Madrigal Pharmaceuticals | Meals · 2025-03-12 | Rezdiffra | $121 |
| Abbvie | Meals · 2025-03-04 | Skyrizi | $9 |
| Janssen Biotech | Meals · 2025-03-03 | Tremfya | $24 |
| Madrigal Pharmaceuticals | Meals · 2025-02-28 | Rezdiffra | $6 |
| Genzyme | Meals · 2025-02-27 | Dupixent | $15 |
| Abbvie | Meals · 2025-02-26 | Rinvoq | $24 |
| Abbvie | Meals · 2025-02-25 | Linzess | $11 |
| Aimmune Therapeutics | Meals · 2025-02-20 | Vowst | $6 |
| Abbvie | Meals · 2025-02-18 | Creon | $6 |
| Aimmune Therapeutics | Meals · 2025-02-13 | Vowst | $3 |
| Madrigal Pharmaceuticals | Meals · 2025-02-11 | Rezdiffra | $28 |
| Genzyme | Meals · 2025-02-04 | Dupixent | $19 |
| Aimmune Therapeutics | Meals · 2025-02-04 | Vowst | $8 |
| Janssen Biotech | Meals · 2025-02-01 | Tremfya | $22 |
| Abbvie | Meals · 2025-01-30 | Skyrizi | $7 |
| Abbvie | Meals · 2025-01-28 | Mavyret | $19 |
| Madrigal Pharmaceuticals | Meals · 2025-01-28 | Rezdiffra | $21 |
| Aimmune Therapeutics | Meals · 2025-01-27 | Vowst | $6 |
| Boston Scientific | Meals · 2025-01-25 | General - Biliary Devices | $32 |
| Ironwood Pharmaceuticals | Meals · 2025-01-24 | Linzess | $14 |
| Aimmune Therapeutics | Meals · 2025-01-23 | Vowst | $11 |
| Abbvie | Meals · 2025-01-21 | Rinvoq | $26 |
| Phathom Pharmaceuticals | Meals · 2025-01-21 | Voquezna | $8 |
| Aimmune Therapeutics | Meals · 2025-01-16 | Vowst | $5 |
| Abbvie | Meals · 2025-01-14 | Rinvoq | $12 |
| Abbvie | Meals · 2025-01-10 | Linzess | $9 |
| Aimmune Therapeutics | Meals · 2025-01-07 | Vowst | $6 |
| Boston Scientific | Meals · 2025-01-03 | General - Biliary Devices | $47 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $3,057
| Abbvie | Rinvoq | $952 | 53 payments
|
| Boston Scientific | X-Tack Endoscopic Helix Tacking System | $482 | 11 payments
|
| Janssen Biotech | Tremfya | $408 | 18 payments
|
| Aimmune Therapeutics | Vowst | $308 | 31 payments
|
| Gilead Sciences | Livdelzi | $150 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $131 | 10 payments
|
| E.R. Squibb & Sons L.L.C. | None | $122 | 1 payment
|
| Phathom Pharmaceuticals | Voquezna | $98 | 6 payments
|
| Ardelyx | Ibsrela | $86 | 5 payments
|
| Pfizer | Xeljanz | $72 | 4 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $50 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $38 | 1 payment
|
| Lilly USA | Omvoh | $32 | 1 payment
|
| Organon | Renflexis | $27 | 1 payment
|
| Fresenius Kabi USA | Idacio | $26 | 1 payment
|
| Genzyme | Dupixent | $22 | 1 payment
|
| Ultragenyx Pharmaceutical | Crysvita | $21 | 1 payment
|
| Albireo Pharma | Iqirvo | $20 | 1 payment
|
| Ironwood Pharmaceuticals | Linzess | $14 | 1 payment
|
2023: $1,683
| AbbVie | Rinvoq | $465 | 38 payments
|
| Boston Scientific | Autotome Rx 49 | $245 | 7 payments
|
| Janssen Biotech | Stelara | $221 | 17 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $213 | 16 payments
|
| Celgene | Zeposia | $213 | 16 payments
|
| Regeneron Healthcare Solutions | Dupixent | $80 | 3 payments
|
| Pfizer | Xeljanz | $64 | 4 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $37 | 2 payments
|
| Merck Sharp & Dohme | Dificid | $29 | 1 payment
|
| Braintree Laboratories | Sutab | $23 | 1 payment
|
| Micro-tech Endoscopy USA | Lockado | $22 | 2 payments
|
| QOL Medical | Sucraid | $22 | 1 payment
|
| Shield Therapeutics | Accrufer | $19 | 1 payment
|
| Nestle Healthcare Nutrition | Vowst | $16 | 1 payment
|
| Ironwood Pharmaceuticals | Linzess | $14 | 1 payment
|
2022: $2,129
| Abbvie | Rinvoq | $690 | 51 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $372 | 21 payments
|
| Janssen Biotech | Stelara | $370 | 28 payments
|
| Boston Scientific | General - Biliary Devices | $236 | 18 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $96 | 4 payments
|
| Celgene | Zeposia | $56 | 3 payments
|
| Daiichi Sankyo | Injectafer | $50 | 2 payments
|
| Pfizer | Xeljanz | $47 | 3 payments
|
| Genzyme | Dupixent | $41 | 2 payments
|
| Ferring Pharmaceuticals | Cimzia | $35 | 2 payments
|
| Braintree Laboratories | Sutab | $32 | 1 payment
|
| Gilead Sciences | None | $25 | 1 payment
|
| QOL Medical | Sucraid | $23 | 1 payment
|
| RedHill Biopharma | Talicia | $22 | 1 payment
|
| Intercept Pharmaceuticals | Ocaliva | $18 | 1 payment
|
| Nestle HealthCare Nutrition | Zenpep | $16 | 1 payment
|
2021: $816
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $198 | 18 payments
|
| Boston Scientific | Exalt | $191 | 5 payments
|
| AbbVie | Humira | $179 | 16 payments
|
| Janssen Biotech | Stelara | $117 | 7 payments
|
| Takeda Pharmaceuticals U.S.A. | Motegrity | $33 | 2 payments
|
| Pfizer | Xeljanz | $30 | 2 payments
|
| Gilead Sciences | None | $26 | 2 payments
|
| Ironwood Pharmaceuticals | Linzess | $15 | 1 payment
|
| Celgene | Zeposia | $14 | 1 payment
|
| Nestle HealthCare Nutrition | Zenpep | $14 | 1 payment
|
2020: $102
| AbbVie | Humira | $28 | 2 payments
|
| Intercept Pharmaceuticals | Ocaliva | $24 | 1 payment
|
| Ironwood Pharmaceuticals | Linzess | $18 | 1 payment
|
| Boston Scientific | General - Pain Management | $16 | 1 payment
|
| Daiichi Sankyo | Injectafer | $16 | 1 payment
|
2019: $687
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $135 | 2 payments
|
| Janssen Scientific Affairs | Stelara | $125 | 1 payment
|
| AbbVie | Humira | $119 | 11 payments
|
| Janssen Biotech | Stelara | $78 | 6 payments
|
| Allergan | Linzess | $49 | 3 payments
|
| Pfizer | Xeljanz | $47 | 3 payments
|
| Boston Scientific | General - Gi Dilatation | $34 | 1 payment
|
| Braintree Laboratories | Motofen | $31 | 2 payments
|
| Shionogi | Mulpleta | $21 | 1 payment
|
| Ferring Pharmaceuticals | Clenpiq | $18 | 1 payment
|
| Shire North American Group | Gattex | $17 | 1 payment
|
| Gilead Sciences | None | $15 | 1 payment
|
Professional record
- NPI
- 1437114113
- Licence
- TX M2891Texas M2891: Canc Non-Renewal
- Trained
- Saint Louis University School of Medicine, 1987
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 7095 N Chestnut Ave Ste 101, Fresno, CA, 93720
- NPI first listed
- 2006-04-18
- NPI last updated
- 2018-09-27
This is when the NPI record was last certified, not a medical board exam.